The Patents (Isle of Man) Order 2013

36.  Before Schedule 1 insert— U.K.

Section 60(5)(g)

“SCHEDULE A1 U.K. Derogation from patent protection in respect of biotechnological inventions

Interpretation U.K.

1.   In this Schedule—

“the Council Regulation” means Council Regulation (EC) No. 2100/94 of 27th July 1994 on Community plant variety rights(1) [F1 as it had effect immediately before exit day];

“farmer’s own holding” means any land which a farmer actually exploits for plant growing, whether as his property or otherwise managed under his own responsibility and on his own account;

“the gazette” means the gazette published under section 34 of the Plant Varieties and Seeds Act 1964(2);

“protected material” means plant propagating material which incorporates material subject to a patent;

“relevant activity” means the use by a farmer of the product of his harvest for propagation or multiplication by him on his own holding, where the product of the harvest constitutes or contains protected material;

“relevant rights holder” means the proprietor of a patent to which protected material is subject;

“seed” includes seed potatoes;

“seed year” means the period from 1st July in one year to 30th June in the following year, both dates inclusive.

Specified species U.K.

2.   Section 60(5)(g) applies only to varieties of the following plant species and groups:

Name	Common Name
Fodder plants
Cicer arietinum L.	Chickpea milkvetch
Lupinus luteus L.	Yellow lupin
Medicago sativa L.	Lucerne
Pisum sativum L. (partim)	Field pea
Trifolium alexandrinum L.	Berseem/Egyptian clover
Trifolium resupinatum L.	Persian clover
Vicia faba	Field bean
Vicia sativa L	Common vetch
Cereals
Avena sativa	Oats
Hordeum vulgare L.	Barley
Oryza sativa L.	Rice
Phalaris canariensis L.	Canary grass
Secale cereale L.	Rye
X Triticosecale Wittm.	Triticale
Triticum aestivum L. emend. Fiori et Paol.	Wheat
Triticum durum Desf.	Durum wheat
Triticum spelta L.	Spelt wheat
Potatoes
Solanum tuberosum	Potatoes
Oil and fibre plants
Brassica napus L. (partim)	Swede rape
Brassica rapa L. (partim)	Turnip rape
Linum usitatissimum	Linseed with the exclusion of flax

Liability to pay equitable remuneration U.K.

3.— (1) If a farmer’s use of protected material is authorised by section 60(5)(g), he shall, at the time of the use, become liable to pay the relevant rights holder equitable remuneration.

(2) That remuneration must be sensibly lower than the amount charged for the production of protected material of the same variety in the same area with the holder’s authority.

(3) Remuneration is to be taken to be sensibly lower if it would be taken to be sensibly lower within the meaning of Article 14(3) fourth indent of the Council Regulation.

Exemption for small farmers U.K.

4.— (1) Paragraph 3 does not apply to a farmer who is considered to be a small farmer for the purposes of Article 14(3) third indent of the Council Regulation.

(2) It is for a farmer who claims to be a small farmer to prove that he is such a farmer.

Information to be supplied by farmer U.K.

5.— (1) At the request of a relevant rights holder (“H”), a farmer must tell H—

(a) his name and address;

(b) whether he has performed a relevant activity; and

(c) if he has performed such an activity, the address of the holding on which he performed it.

(2) If the farmer has performed such an activity, he must tell H whether he is—

(a) liable to pay remuneration as a result of paragraph 3; or

(b) not liable because he is a small farmer.

(3) If the farmer has told H that he is liable to pay remuneration as a result of paragraph 3, he must tell H—

(a) the amount of the protected material used;

(b) whether the protected material has been processed for planting; and

(c) if it has, the name and address of the person who processed it.

(4) The farmer must comply with sub-paragraphs (2) and (3) when complying with sub-paragraph (1).

(5) If the farmer has told H that he is liable to pay remuneration as a result of paragraph 3, he must (if H asks him to do so) tell H—

(a) whether he used any protected material with the authority of H within the same seed year; and

(b) if he did, the amount used and the name and address of the person who supplied it.

Information to be supplied by seed processor U.K.

6.— (1) On the request of a relevant rights holder, a seed processor shall supply the following information—

(a) the name and address of the seed processor;

(b) the address of the seed processor’s principal place of business; and

(c) whether the seed processor has processed seed of a species specified in paragraph 2 above.

(2) If the seed processor has processed seed of a species specified in paragraph 2 above he shall also supply the following information with the information referred to in sub-paragraph (1)—

(a) the name and address of the person for whom the processing was carried out;

(b) the amount of seed resulting from the processing;

(c) the date processing commenced;

(d) the date processing was completed;

(e) the place where processing was carried out.

Information to be supplied by relevant rights holder U.K.

7.   On the request of a farmer or a seed processor a relevant rights holder shall supply the following information—

(a) his name and address; and

(b) the amount of royalty charged for certified seed of the lowest certification category for seed containing that protected material.

Period in respect of which inquiry may be made U.K.

8.   A request may be made under paragraph 5, 6, and 7 in respect of the current seed year and the three preceding seed years.

Restriction on movement for processing from the holding U.K.

9.   No person shall remove or cause to be removed from a holding protected material in order to process it unless—

(a) he has the permission of the relevant rights holder in respect of that protected material;

(b) he has taken measures to ensure that the same protected material is returned from processing as is sent for processing and the processor has undertaken to him that the processor has taken measures to ensure that the same protected material is returned from processing as is sent for processing; or

(c) he has the protected material processed by a seed processor on the list of processors referred to in the gazette as being permitted to process seed away from a holding.

Confidentiality U.K.

10.— (1) A person who obtains information pursuant to this Schedule shall owe an obligation of confidence in respect of the information to the person who supplied it.

(2) Sub-paragraph (1) shall not have effect to restrict disclosure of information—

(a) for the purposes of, or in connection with, establishing the amount to be paid to the holder of rights pursuant to paragraph 3 and obtaining payment of that amount,

(b) for the purposes of, or in connection with, establishing whether a patent has been infringed, or

(c) for the purposes of, or in connection with, any proceedings for the infringement of a patent.

Formalities U.K.

11.— (1) A request for information under this Schedule, and any information given in response to such a request, must be in writing.

(2) Information requested under this Schedule must be given—

(a) within 28 days; or

(b) if the request specifies a longer period, within the specified period.

Remedies U.K.

12.— (1) If, in response to a request under this Schedule, a person—

(a) knowingly fails to provide information which he is required by this Schedule to give, or

(b) refuses to provide any such information,

the court may order him to provide it.

(2) Sub-paragraph (1) does not affect any of the court’s other powers to make orders.

(3) A person who knowingly provides false information in response to a request under this Schedule is liable in damages to the person who made the request.

(4) In any action for damages under sub-paragraph (3) the court must have regard, in particular to—

(a) how flagrant the defendant was in providing the false information, and

(b) any benefit which accrued to him as a result of his providing false information,

and shall award such additional damages as the justice of the case may require.

Section 76A

SCHEDULE A2 U.K. Biotechnological Inventions

1.   An invention shall not be considered unpatentable solely on the ground that it concerns—

(a) a product consisting of or containing biological material; or

(b) a process by which biological material is produced, processed or used.

2.   Biological material which is isolated from its natural environment or produced by means of a technical process may be the subject of an invention even if it previously occurred in nature.

3.   The following are not patentable inventions—

(a) the human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene;

(b) processes for cloning human beings;

(c) processes for modifying the germ line genetic identity of human beings;

(d) uses of human embryos for industrial or commercial purposes;

(e) processes for modifying the genetic identity of animals which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes;

(f) any variety of animal or plant or any essentially biological process for the production of animals or plants, not being a microbiological or other technical process or the product of such a process.

4.   Inventions which concern plants or animals may be patentable if the technical feasibility of the invention is not confined to a particular plant or animal variety.

5.   An element isolated from the human body or otherwise produced by means of a technical process, including the sequence or partial sequence of a gene, may constitute a patentable invention, even if the structure of that element is identical to that of a natural element.

6.   The industrial application of a sequence or partial sequence of a gene must be disclosed in the patent application as filed.

7.   The protection conferred by a patent on a biological material possessing specific characteristics as a result of the invention shall extend to any biological material derived from that biological material through propagation or multiplication in an identical or divergent form and possessing those same characteristics.

8.   The protection conferred by a patent on a process that enables a biological material to be produced possessing specific characteristics as a result of the invention shall extend to biological material directly obtained through that process and to any other biological material derived from the directly obtained biological material through propagation or multiplication in an identical or divergent form and possessing those same characteristics.

9.   The protection conferred by a patent on a product containing or consisting of genetic information shall extend to all material, save as provided for in paragraph 3(a) above, in which the product is incorporated and in which the genetic information is contained and performs its function.

10.   The protection referred to in paragraphs 7, 8 and 9 above shall not extend to biological material obtained from the propagation or multiplication of biological material placed on the market by the proprietor of the patent or with his consent, where the multiplication or propagation necessarily results from the application for which the biological material was marketed, provided that the material obtained is not subsequently used for other propagation or multiplication.

11.   In this Schedule—

“essentially biological process” means a process for the production of animals and plants which consists entirely of natural phenomena such as crossing and selection;

“microbiological process” means any process involving or performed upon or resulting in microbiological material;

“plant variety” means a plant grouping within a single botanical taxon of the lowest known rank, which grouping can be—

(a)

defined by the expression of the characteristics that results from a given genotype or combination of genotypes; and

(b)

distinguished from any other plant grouping by the expression of at least one of the said characteristics; and

(c)

considered as a unit with regard to its suitability for being propagated unchanged.

[F2 SCHEDULE A3 U.K. EUROPEAN PATENT WITH UNITARY EFFECT

Meaning of “relevant statutory provisions” U.K.

1.   In this Schedule “relevant statutory provisions” means—

(a) the provisions of this Act which, by virtue of paragraph 2, apply in relation to the European patent with unitary effect, and

(b) the other provisions of this Act which, by virtue of the Unitary Patent Regulation, are to be treated as applying in relation to the European patent with unitary effect (see, in particular, Article 7 of that Regulation).

Provisions applied by this Schedule to the European patent with unitary effect U.K.

2.   The following provisions of this Act apply in relation to a European patent with unitary effect, subject to paragraphs 3 and 4—

• section 48 (compulsory licences: general);

• section 48A (compulsory licences: WTO proprietors);

• section 48B (compulsory licences: other cases);

• section 49 (provisions about licences under section 48);

• section 50 (exercise of powers on applications under section 48);

• section 50A (powers exercisable following merger and market investigations);

• section 51 (powers exercisable in consequence of report of Competition and Markets Authority);

• section 52 (opposition, appeal and arbitration);

• section 53 (compulsory licences; supplementary provisions);

• section 54 (special provisions where patented invention is being worked abroad);

• section 55 (use of patented inventions for services of the Crown);

• section 56 (interpretation, etc., of provisions about Crown use);

• section 57 (rights of third parties in respect of Crown use);

• section 57A (compensation for loss of profit);

• section 58(1) to (6) and (9A) to (13) (references of disputes as to Crown use);

• section 59 (special provisions as to Crown use during emergency);

• section 60 (meaning of infringement);

• section 64 (right to continue use begun before priority date);

• section 73(2) to (4) (Comptroller’s power to revoke patents on his own initiative);

• section 74A (opinions on matters prescribed in the rules);

• section 74B (reviews of opinions under section 74A);

• section 76A (biotechnological inventions);

• section 77(4) to (5A) (effect of European patent (UK));

• section 80(1) (authentic text of European patents and patent applications);

• sections 97 to 100 (legal proceedings) so far as they relate to proceedings which do not fall within the exclusive jurisdiction of the Unified Patent Court as set out in paragraph 1 of Schedule A4;

• section 101 (exercise of comptroller’s discretionary powers);

• section 102 (right of audience, &c in proceedings before comptroller);

• sections 103 (extension of privilege for communications with solicitors relating to patent proceedings) and 105 (extension of privilege in Scotland for communications relating to patent proceedings) so far as they relate to proceedings before the comptroller;

• section 107 (costs and expenses in proceedings before the comptroller);

• section 108 (licences granted by order of comptroller);

• section 110 (unauthorised claim of patent rights);

• section 116 (immunity of department as regards official acts);

• section 118 (information about patent applications and patents, and inspection of documents);

• section 123 (rules);

• section 124 (rules, regulations and orders; supplementary);

• section 125 (extent of invention);

• section 128A (EU compulsory licences);

• section 128B (supplementary protection certificates).

Manner of application of relevant statutory provisions U.K.

3.   The relevant statutory provisions apply in relation to a European patent with unitary effect in the same way as they apply in relation to a European patent (UK).

Modifications of relevant statutory provisions U.K.

4.— (1) In their application in relation to the European patent with unitary effect, the relevant statutory provisions which are referred to in this paragraph have effect subject to the modifications set out in this paragraph.

(2) In section 7(2)(b), the reference to the United Kingdom is a reference to any of the Participating Member States.

(3) In sections 30(7) and 31(7), references to proceedings by virtue of section 61 or 69 are references to equivalent proceedings in the Unified Patent Court.

(4) In sections 33(1)(a), 33(4), 37(2), 37(7), 38(2) and 38(3), the reference to registration is a reference to registration in the Register for unitary patent protection.

(5) In sections 48(1)(b), 48B(4), 50A(4), 51(3), 53(3), and 53(4), the reference to the register is a reference to the Register for unitary patent protection.

(6) In sections 48(2)(b), 50A(4), 51(3), 53(3), 53(4) and 53(5), the reference to making an entry is a reference to directing the making of an entry.

(7) In sections 48B(2)(b) and 50(2)(a), the reference to the journal is a reference to the European Patent Bulletin.

(8) In section 55(5)(b), the reference to the Patent Office is a reference to the European Patent Office.

(9) In section 59(2), the reference to section 69 includes a reference to Article 67 of the European Patent Convention.

(10) In section 60—

(a) in subsections (1), (2), and (5)(d), (e) and (f), the references to the United Kingdom are references to the territory of a Contracting Member State in which the European patent with unitary effect has effect;

(b) in subsection (7)—

(i) in the definition of “relevant ship” and “relevant aircraft, hovercraft or vehicle”, the reference to the United Kingdom is a reference to a Contracting Member State in which the European patent with unitary effect has effect; and

(ii) in the definition of “exempted aircraft”, the reference to an aircraft to which section 89 of the Civil Aviation Act 1982 applies is a reference to an aircraft other than an aircraft of a Contracting Member State in which the European patent with unitary effect has effect.

Interpretation U.K.

5.   In this Schedule—

(a) “Contracting Member State” has the same meaning as in Article 2(c) of the Agreement on a Unified Patent Court;

(b) the following expressions have the same meanings as in Article 2 of the Unitary Patent Regulation—

• Participating Member State;

• Register for unitary patent protection; and

(c) in relation to the United Kingdom, references to a Contracting Member State or a Participating Member State are to be construed in accordance with section 132(2).”].

Textual Amendments

F1 Words in Sch. para. 36 inserted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(4); 2020 c. 1, Sch. 5 para. 1(1)

F2 Words in Sch. para. 36 inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 5 (with art. 3)

Commencement Information

I1 Sch. para. 36 in force at 11.11.2013, see art. 1

(1)

OJ No. L 227, 1.9.1994, p.1.

(2)

1964 c.14.